Filippo Pagani

EPSILoN: A Prognostic Score for Immunotherapy in Advanced Non-Small-Cell Lung Cancer: A Validation Cohort

Arsela Prelaj, Roberto Ferrara, Sara Elena Rebuzzi et al. · Cancers · 2019 · 78 citations · Full text

Medicine, Immunology, Oncology +17

Prognostic impact of ATM mutations in patients with metastatic colorectal cancer

Giovanni Randon, Giovanni Fucà, Daniele Rossini et al. · Scientific Reports · 2019 · 68 citations · Full text

Medicine, Molecular Genetics, Oncology +15

Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer

Giulia Galli, Alessandro De Toma, Filippo Pagani et al. · Lung Cancer · 2019 · 65 citations · Full text

Medicine, Immunology, Oncology +13

Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden

Filippo Pietrantonio, Fotios Loupakis, Giovanni Randon et al. · The Oncologist · 2020 · 50 citations · Full text

Medicine, Immunology, Oncology +17

Variant allele frequency in baseline circulating tumour DNA to measure tumour burden and to stratify outcomes in patients with RAS wild-type metastatic colorectal cancer: a translational objective of the Valentino study

Paolo Manca, Salvatore Corallo, Sara Lonardi et al. · British Journal of Cancer · 2021 · 36 citations · Full text

Medicine, Genetics, Oncology +17